Skip to content

Clinical trials

Phase 2/3 Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2/3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20093
20101
20112
20131
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oregon Health and Science University2
VA Office of Research and Development2
Brown, Theodore R., M.D., MPH1
Immune Response BioPharma, Inc.1
Neurologique Foundation, Inc.1
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC1
State University of New York at Buffalo1
Texas Tech University Health Sciences Center1
University of Missouri, Kansas City1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis13
Brain Injuries, Traumatic1
Cerebral Palsy1
Cognition Disorders1
Cognitive Dysfunction1
Deglutition Disorders1
Fatigue1
Hemiplegia1
Multiple Sclerosis, Chronic Progressive1
Muscle Spasticity1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.